Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical therapeutic problems and meaningfully improve people’s lives. We apply innovative drug delivery technology and scientific expertise to redesign important medicines. Our initial focus, supported by our current approved products and late stage pipeline, is to improve medications and outcomes for patients with central nervous system (CNS) conditions.
Over the past decade, Aquestive Therapeutics has applied its innovative drug delivery technology to become the undisputed leader in developing and delivering medications through film. Our team of scientists and innovators work to solve important therapeutic problems with redesigned medicines. Whether we are working alone, or in collaboration with industry partners, we aim to transform the treatment landscape with new medicines that deliver meaningful clinical benefit and are accessible for more people. Patient and caregiver needs are at the heart of every advance we make – in CNS and beyond.
Keith J. Kendall
Chief Executive Officer
We consult with and listen to our patients. Our technologies aim to address shortfalls in medication design that make it hard for patients to use the medicines they’re prescribed.
Our therapeutic solutions make life-saving medications available to those who need them most by enhancing the way they are delivered.
We are focused problem solvers who work to empower patients and their caregivers. Our team hails from a variety of backgrounds and disciplines, and has created a collaborative culture where different viewpoints are valued and challenging the status quo is the norm.
We’re fortunate to have experienced industry leaders on our active Board of Directors.
